Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
LRMR
Stock Latest News
Company Announcements
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
20d ago
8K
LRMR
Premium
Company Announcements
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
24d ago
LRMR
Premium
Ratings
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
25d ago
LRMR
Premium
Ratings
Positive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
25d ago
LRMR
Premium
The Fly
Larimar Therapeutics reports Q3 EPS (61c), consensus (42c)
25d ago
LRMR
Premium
The Fly
Larimar Therapeutics sees cash runway into 4Q26
25d ago
LRMR
Premium
Company Announcements
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia
1M ago
LRMR
Premium
Company Announcements
Larimar Therapeutics Reports Promising Clinical Data Update
2M ago
8K
LRMR
Premium
Market News
3 Best Stocks to Buy Now, 10/6/2025, According to Top Analysts
2M ago
AMZN
LRMR
Premium
Ratings
Buy Rating for Larimar Therapeutics: Promising Efficacy of Nomla in Friedreich’s Ataxia Amidst Anaphylaxis Concerns
2M ago
LRMR
Premium
The Fly
Larimar Therapeutics price target lowered to $21 from $26 at Oppenheimer
2M ago
LRMR
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
2M ago
BIIB
DSGN
Premium
Market News
3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts
2M ago
SOC
ACVA
Premium
The Fly
Larimar Therapeutics price target lowered to $7 from $10 at Baird
2M ago
LRMR
Premium
Ratings
Buy Rating for Larimar Therapeutics Driven by Promising Data and Unmet Need in Friedreich’s Ataxia
2M ago
LRMR
Premium
The Fly
EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
2M ago
EA
GD
Premium
Ratings
Optimistic Buy Rating for Larimar Therapeutics Amid Promising Data and Safety Adjustments
2M ago
LRMR
Premium
Company Announcements
Larimar Therapeutics Announces Positive Study Results
2M ago
8K
LRMR
Premium
The Fly
Larimar announces 25 mg, 50 mg data from OL study of nomlabofusp
2M ago
LRMR
Premium
The Fly
Larimar Therapeutics provides updates on nomlabofusp program for FA
2M ago
LRMR
Premium
Ratings
Buy Rating for Larimar Therapeutics Driven by Positive Physician Sentiment and Promising Prospects for Nomlabofusp
3M ago
LRMR
Premium
Market News
3 Best Stocks to Buy Now, 9/1/2025, According to Top Analysts
3M ago
APLD
LRMR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
